Editing Angiopathy (section)

==Treatment==
Currently, while there is no cure for angiopathy, there are ways through which the symptoms can be managed. For example, therapies. Treatment options for situations of muscle weakness may include speech, occupational, or physical therapy. Medication can be used for potential seizures and memory loss.<ref name=":0" />

lobar intracerebral hemorrhages(ICH) linked to CAA is often recurring. Due to this high prevalence, when there isn't a clear justification for anticoagulation, doctors usually avoid [[Antiplatelet drug|antiplatelet medicines]] and [[Anticoagulant|anticoagulants]]. Notably, research has shown that people with [[atrial fibrillation]] benefit from restarting anticoagulation.<ref>{{Cite journal |last1=Biffi |first1=A. |last2=Battey |first2=T.W.K. |last3=Ayres |first3=A.M. |last4=Cortellini |first4=L. |last5=Schwab |first5=K. |last6=Gilson |first6=A.J. |last7=Rost |first7=N.S. |last8=Viswanathan |first8=A. |last9=Goldstein |first9=J.N. |last10=Greenberg |first10=S.M. |last11=Rosand |first11=J. |date=2011-11-15 |title=Warfarin-related intraventricular hemorrhage |journal=Neurology |volume=77 |issue=20 |pages=1840–1846 |doi=10.1212/WNL.0b013e3182377e12 |issn=0028-3878 |pmc=3233208 |pmid=22049204}}</ref>

Despite the fact that CAA does not appear to be primarily caused by hypertension, blood pressure reduction has also been linked to advantages in terms of mortality.[8] Blood pressure control reduced the risk of CAA-related ICH by 77%.<ref>{{Cite journal |last1=H |first1=Arima |last2=C |first2=Tzourio |last3=C |first3=Anderson |last4=M |first4=Woodward |last5=MG |first5=Bousser |last6=S |first6=MacMahon |last7=B |first7=Neal |last8=J |first8=Chalmers |date=2010 |title=Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke. |url=https://www.ncbi.nlm.nih.gov/books/NBK556105/ |journal=PROGRESS Collaborative Group |volume=41 |issue=W |pages=394–6 |via=National Institute of Health}}</ref> 

Finally, a small body of research has demonstrated the advantages of using [[immunosuppression]] to treat the inflammatory forms of CAA.<ref>{{Cite journal |last1=Kinnecom |first1=C. |last2=Lev |first2=M. H. |last3=Wendell |first3=L. |last4=Smith |first4=E. E. |last5=Rosand |first5=J. |last6=Frosch |first6=M. P. |last7=Greenberg |first7=S. M. |date=2007-04-24 |title=Course of cerebral amyloid angiopathy-related inflammation |url=https://pubmed.ncbi.nlm.nih.gov/17452586/ |journal=Neurology |volume=68 |issue=17 |pages=1411–1416 |doi=10.1212/01.wnl.0000260066.98681.2e |issn=1526-632X |pmid=17452586}}</ref>